MacroGenics ^Companies

MacroGenics is a biotechnology company that focuses on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. They also develop immune-based products, including monoclonal antibodies and vaccines, to prevent autoimmune disorders and infectious diseases. The company utilizes Fc engineering technology to improve antibody functions and eliminate cancer cells. Founded in 2000 and headquartered in Rockville, Maryland, MacroGenics is dedicated to advancing immunotherapeutics to address critical medical needs.